ESMO Congress 2026 opened in Madrid: spotlight on optimising cancer care?
esmo - The ESMO Congress 2026 opened today in Madrid, over 40,000 attendees expected, more than 6,300 abstracts submitted and around 230 sessions.
AI Summary: The ESMO 2026 Congress kicked off in Madrid with a clear agenda: optimise cancer care across settings. Speakers emphasised translating trial data into practice, tackling health inequities, and refining biomarker‑driven strategies. Expect spirited debates, high‑stakes late‑breaking results, and the usual congress hustle of science, networking and slightly overcaffeinated poster sessions.
- Congress opening: key themes, data and innovation (3)
- Genitourinary advances: bladder preservation, MIBC molecular insights (3)
- GI and targeted therapy: BRAF, ADCs and trial collaborations (3)
- All Other Stories
Congress opening: key themes, data and innovation
Genitourinary advances: bladder preservation, MIBC molecular insights
GI and targeted therapy: BRAF, ADCs and trial collaborations
All Other Stories
Related Stories
ELCC 2026 showcases lung-cancer trials, new data, and collaborations / 6 months
AACR launches Rare Cancers Initiative to accelerate research collaboration / 2 months
AstraZeneca deal to bring sunvozertinib to US expands access for EGFR Exon20 patients / 3 months
DESTINY‑Lung03: T‑DXd shows activity in HER2 lung cancer; triplet stalls / 4 months
Perioperative advances reshape muscle‑invasive bladder cancer care / 2 months
ALTAIR trial probes ctDNA‑guided post‑adjuvant therapy in CRC / 4 months
Perioperative apalutamide plus ADT improves high‑risk prostate outcomes / 4 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Venture Capital, Cybersecurity, Obesity, Alzheimer's disease and look for the RSS link.
StackHealth Time Machine